HOWL
Werewolf Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.98
+1.80%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 0.79x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 2.92x
- Price / sales
- 2.27x
- Price / cash flow
- -1.58x
Enterprise value
- Enterprise value
- $25.7M
- EV / sales
- 1.22x
- EV / EBITDA
- -1.17x
- EV / EBIT
- -1.00x
- Market cap
- $47.6M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026